Reframing Persistence Metrics in Immune-Mediated Inflammatory Diseases: Toward Clinically Meaningful and Patient-Centered Outcomes in Medicine 6P Model
Restricted accessLetterFirst published online 2025
Reframing Persistence Metrics in Immune-Mediated Inflammatory Diseases: Toward Clinically Meaningful and Patient-Centered Outcomes in Medicine 6P Model
Husein-ElAhmedHHusein-ElAhmedS.Assessing the 5-year persistence in positive clinical response with innovative psoriasis treatments: a network meta-analysis of Psoriasis Area and Severity Index score. Clin Exp Dermatol. 2024;49:1148-1155. doi:10.1093/ced/llae131
2.
Borrás-BlascoJRamírez-HerráizENavarro-RuizA.El valor de la persistencia en el modelo de la Medicina 5P en enfermedades crónicas. J Healthc Qual Res. 2023;38:345-348. doi:10.1016/j.jhqr.2023.05.001
3.
Borrás-BlascoJRamírez-HerráizENavarro-RuizA. Persistence within 6P medicine model has value for clinical decision only when adherence is assessed [published online ahead of print August 17, 2025]. Ann Pharmacother. doi:10.1177/10600280251363950
4.
JuntTCalzasciaTTraggiaiE, et al. Defining immune reset: achieving sustained remission in autoimmune diseases. Nat Rev Immunol. 2025;25:528-541. doi:10.1038/s41577-025-01141-w
5.
Borrás-BlascoJRamírez-HerráizENavarro-RuizA.Integration of persistence in the 5P-medicine approach for age-related chronic diseases. Int J Qual Health Care. 2024;36:mzae026. doi:10.1093/intqhc/mzae026
6.
Nouni-GarcíaRRamirez-FamiliaELópez-PinedaA, et al. Methods and validity indicators for measuring adherence and persistence to aspirin in secondary cardiovascular prevention: a systematic review. Front Cardiovasc Med. 202526;12:1570331. doi:10.3389/fcvm.2025.1570331
7.
Báez-GutiérrezNGalindo-GarcíaCRodríguez-RamalloHSánchez-FidalgoS.Adherence and persistence to heart failure guideline-directed medical therapy: a systematic review of studies based on electronic healthcare data. Res Social Adm Pharm. 2025;21:1013-1023. doi:10.1016/j.sapharm.2025.07.005
